1258 Upsala Rd
Sanford, FL 32771
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2023 All rights reserved
SHEACDI09232a
Disclaimer
is resource is for informational purposes only, intended as a quick-reference tool based on the cited
source guideline(s), and should not be used as a substitute for the independent professional judgment
of healthcare providers. Practice guidelines are unable to account for every individual variation
among patients or take the place of clinician judgment, and the ultimate decision concerning the
propriety of any course of conduct must be made by healthcare providers aer consideration of
each individual patient situation. Guideline Central does not endorse any specific guideline(s) or
guideline recommendations and has not independently verified the accuracy hereof. Any use of this
resource or any other Guideline Central resources is strictly voluntary.
Abbreviations
CA-CDI, community-associated CDI; CDC, Centers for Disease Control and Prevention;
CDI, Clostridioides difficile infection; CO-CDI, community-onset CDI; CO-HCFA-CDI,
community-onset, healthcare facility-associated CDI; EPA, US Environmental Protection
Agency; HA-CDI, healthcare-associated CDI; HCF, healthcare facility; HCP, healthcare
personnel; HICPAC, CDC Healthcare Infection Control Practices Advisory Committee;
HO-CDI, healthcare facility-onset CDI; HT-CDI, healthcare facility-onset, treated CDI;
NAAT, nucleic acid amplification test; NHSN, National Healthcare Safety Network; SHEA,
Society for Healthcare Epidemiolog y of America; WHO, World Health Organization
Source
Kociolek LK, Gerding DN, Carrico R, Carling P, Donskey CJ, Dumyati G, Kuhar DT, Loo
VG, Maragakis LL, Pogorzelska-Maziarz M, Sandora TJ, Weber DJ, Yokoe D, Dubberke ER.
Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update.
Infect Control Hosp Epidemiol. 2023;44(4):527–549. doi:10.1017/ice.2023.18.
